Drug Trial Radar · NCT07186634
PeRiOperative Medicine Platform Trial
Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
7,800
Planned (sponsor's estimate)
Start
Apr 6, 2026
Primary completion
Dec 2035
Study completion Dec 2035
Sponsor
- Lead sponsor
- Monash UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Alfred; Wellington Hospital
- First posted
- Sep 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Our specific aims are to investigate whether conservative (≤30%), intermediate (50%), or liberal (80%) inspired oxygen during and immediately after surgery: Aim 1: Reduces surgical site infections (SSIs or "wound infections") and other healthcare-associated infections (pneumonia and sepsis). Aim 2: Reduces a pooled composite of serious postoperative complications, leading to a faster and more complete recovery after surgery, and thus increases "days alive and at home up to 30 days after surgery" (DAH30). Primary hypothesis: Liberal (80%) oxygen concentration delivered with anesthesia in patients undergoing major surgery reduces the incidence of SSIs after surgery compared to conservative (≤30%) or intermediate (50%) oxygen concentration. Secondary hypothesis: Hyperoxia (50-80%) delivered with anesthesia in patients undergoing major surgery increases the incidence of pulmonary and other complications after surgery compared to conservative (≤30%) oxygen concentration, resulting in fewer Days At Home (DAH). PROMPT enrolls patients undergoing elective or semi-elective surgery.
Conditions
- Surgical Site Infection After Major Surgery
- Anaesthesia
- Major Complications
- Quality of Recovery (QoR-15)
- Quality of Life
Interventions
Liberal inspired oxygenDrug
The concentration of Oxygen will differ according to the randomisation
Conservative inspired oxygenDrug
Conservative inspired oxygen
Intermediate inspired oxygenDrug
Intermediate inspired oxygen
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surgical Site InfectionTime frame: 30 days
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
The Alfred
Melbourne, Victoria, Australia · Recruiting
Wellington Hospital
Wellington, NZ, New Zealand · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.